Gabriela M Bowden

Title: Gabriela M Bowden: Innovator in Antibody Research

Introduction

Gabriela M Bowden is a prominent inventor based in Sugar Land, TX (US). She has made significant contributions to the field of antibody research, particularly in relation to methicillin-resistant Staphylococcus aureus (MRSA). Her work focuses on developing innovative methods for treating and preventing infections caused by this resistant strain of bacteria.

Latest Patents

Gabriela M Bowden holds a patent for "Antibodies recognizing a highly expressed putative antigen of CA-MRSA and methods of use." This invention provides MSCRAMM® proteins that are putative highly-expressed antigens from community-associated MRSA (CA-MRSA). The patent outlines methods for generating antibodies that can bind to these antigens, which are crucial for treating or preventing MRSA infections. The invention also includes nucleic acids coding for these proteins and pharmaceutical compositions or vaccines that incorporate the proteins or antibodies in combination with a pharmaceutically acceptable vehicle, carrier, or excipient. She has 1 patent to her name.

Career Highlights

Gabriela M Bowden is affiliated with The Texas A&M University System, where she continues her research and development in the field of immunology. Her work has garnered attention for its potential impact on public health, particularly in combating antibiotic-resistant infections.

Collaborations

Gabriela has collaborated with notable colleagues such as Magnus A Hook and Maria Labandeira-Rey. These partnerships have enhanced her research efforts and contributed to the advancement of knowledge in her field.

Conclusion

Gabriela M Bowden is a dedicated inventor whose work in antibody research is paving the way for new treatments against MRSA infections. Her innovative approaches and collaborations highlight her commitment to improving healthcare outcomes.